(19)
(11) EP 3 518 904 A1

(12)

(43) Date of publication:
07.08.2019 Bulletin 2019/32

(21) Application number: 17769011.2

(22) Date of filing: 11.09.2017
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61P 39/04(2006.01)
A61K 31/4196(2006.01)
A61P 3/00(2006.01)
(86) International application number:
PCT/EP2017/072747
(87) International publication number:
WO 2018/059922 (05.04.2018 Gazette 2018/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 30.09.2016 EP 16191967

(71) Applicant: Synthon B.V.
6545 CM Nijmegen (NL)

(72) Inventors:
  • FRADERA GELABERT, Sara
    08830 Sant Boi de Llobregat (ES)
  • VIVANCOS MARTINEZ, Marta
    08830 Sant Boi de Llobregat (ES)
  • ÁLVAREZ FERNÁNDEZ, Lisardo
    08830 Sant Boi de Llobregat (ES)
  • VELADA CALZADA, Jose
    6545 CM Nijmegen (NL)

(74) Representative: Overeem, Arjanne 
Synthon B.V. IP Research P.O. Box 7071
6503 GN Nijmegen
6503 GN Nijmegen (NL)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING DEFERASIROX